Which mutual funds hold Gilead Sciences Inc?
3 Direct Growth mutual fund schemes held Gilead Sciences Inc (Healthcare) at the end of Aug 2026, the same number as in Jul 2026. The largest position was in Edelweiss Msci India Domestic & World Healthcare 45 Index Fund, at 1.24% of the scheme.
- Schemes holding
- 3
- New entries
- 0
- Fully exited
- 0
- Increased
- 0
- Decreased
- 0
- Average weight
- 0.77%
By fund type: Index 3
What changed in Aug 2026
vs Jul 2026 · by number of sharesNo scheme we track bought or sold Gilead Sciences Inc this month.
Weight shown as last month → this month. Only the 1,622 schemes with portfolios for both months are compared.
All 3 schemes holding Gilead Sciences Inc
Sorted by weight in the scheme| # | Scheme | Category | Weight | Shares | This month |
|---|---|---|---|---|---|
| 1 | Edelweiss Msci India Domestic & World Healthcare 45 Index Fund Edelweiss | Equity Index | 1.24% | 1,772 | Unchanged |
| 2 | ICICI Prudential Nasdaq 100 Index Fund ICICI Prudential | Equity Index | 0.80% | 20,507 | Unchanged |
| 3 | Motilal Oswal S&P 500 Index Fund Motilal Oswal | Equity Index | 0.27% | 9,012 | Unchanged |
Explore Gilead Sciences Inc changes →What funds bought and sold this month →All stocks A–Z →
Want to know what this means for your portfolio?
Owning Gilead Sciences Inc through several funds at once is common — and easy to miss. Sulekha Sen can check what your funds really hold and whether it fits your goals.
Book a free 30-min call →Data: each AMC’s SEBI-mandated monthly portfolio disclosure, Aug 2026 (compared with Jul 2026). Holdings change after month-end. Direct Plan – Growth schemes only; one row per scheme. Changes are measured by number of shares or units, not portfolio weight. Not investment advice, and not a recommendation to buy, sell or hold any security or scheme. Mutual fund investments are subject to market risks, read all scheme related documents carefully.